Advertisement

Obesity Surgery

, Volume 24, Issue 2, pp 299–309 | Cite as

Development of Ulcer Disease After Roux-en-Y Gastric Bypass, Incidence, Risk Factors, and Patient Presentation: A Systematic Review

  • Usha K. Coblijn
  • Amin B. Goucham
  • Sjoerd M. Lagarde
  • Sjoerd D. Kuiken
  • Bart A. van Wagensveld
Review Article

Abstract

Laparoscopic Roux-en-Y gastric bypass (LRYGB) is the gold standard in bariatric surgery. A long-term complication can be marginal ulceration (MU) at the gastrojejunostomy. The mechanism of development is unclear and symptoms vary. Management and prevention is a continuous subject of debate. The aim was to assess the incidence, mechanism, symptoms, and management of MU after LRYGB by means of a systematic review. Forty-one studies with a total of 16,987 patients were included, 787 (4.6 %) developed MU. The incidence of MU varied between 0.6 and 25 %. The position and size of the pouch, smoking, and nonsteroidal inflammatory drugs usage are associated with the formation of MU. In most cases, MU is adequately treated with proton pump inhibitors, sometimes reoperation is required. Laparoscopic approach is safe and effective.

Keywords

Anastomotic ulcer Bariatric surgery Bleeding ulcer Gastric bypass Ischemic ulcer Marginal ulcer Morbid obesity Perforation Roux-en-Y gastric bypass RYGB Ulcer 

Notes

Acknowledgments

SM Lagarde is supported by a Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society Fellowship, UVA 2013-5853). Special thanks to Mrs. H. Swindin for her knowledge and assistance.

Disclosure

All authors report no conflict of interest.

References

  1. 1.
    Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–55.PubMedCrossRefGoogle Scholar
  2. 2.
    WHO Director-General. Life in the 21st century: a vision for all. Geneva: World Health Organization; 1998.Google Scholar
  3. 3.
    Khaodhiar L, McCowen KC, Blackburn GL. Obesity and its comorbid conditions. Clin Cornerstone. 1999;2(3):17–31.PubMedCrossRefGoogle Scholar
  4. 4.
    Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;2, CD003641.PubMedGoogle Scholar
  5. 5.
    Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Mingrone G, Panunzi S, De GA, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.PubMedCrossRefGoogle Scholar
  7. 7.
    Siddiqui A, Livingston E, Huerta S. A comparison of open and laparoscopic Roux-en-Y gastric bypass surgery for morbid and super obesity: a decision-analysis model. Am J Surg. 2006;192(5):e1–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Schneider BE, Villegas L, Blackburn GL, et al. Laparoscopic gastric bypass surgery: outcomes. J Laparoendosc Adv Surg Tech A. 2003;13(4):247–55.PubMedCrossRefGoogle Scholar
  9. 9.
    Sanyal AJ, Sugerman HJ, Kellum JM, et al. Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol. 1992;87(9):1165–9.PubMedGoogle Scholar
  10. 10.
  11. 11.
    MacLean LD, Rhode BM, Nohr C, et al. Stomal ulcer after gastric bypass. J Am Coll Surg. 1997;185(1):1–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Sapala JA, Wood MH, Sapala MA, et al. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg. 1998;8(5):505–16.PubMedCrossRefGoogle Scholar
  13. 13.
    Howard L, Malone M, Michalek A, et al. Gastric bypass and vertical banded gastroplasty—a prospective randomized comparison and 5-year follow-up. Obes Surg. 1995;5(1):55–60.PubMedCrossRefGoogle Scholar
  14. 14.
    Felix EL, Kettelle J, Mobley E, et al. Perforated marginal ulcers after laparoscopic gastric bypass. Surg Endosc. 2008;22(10):2128–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Azagury DE, Abu Dayyeh BK, Greenwalt IT, et al. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy. 2011;43(11):950–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Caruana JA, McCabe MN, Smith AD, et al. Risk of massive upper gastrointestinal bleeding in gastric bypass patients taking clopidogrel. Surg Obes Relat Dis. 2007;3(4):443–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients—what have we learned? Obes Surg. 2000;10(6):509–13.PubMedCrossRefGoogle Scholar
  18. 18.
    Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.PubMedCrossRefGoogle Scholar
  19. 19.
    Bendewald FP, Choi JN, Blythe LS, et al. Comparison of hand-sewn, linear-stapled, and circular-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2011;21(11):1671–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Capella JF, Capella RF. Staple disruption and marginal ulceration in gastric bypass procedures for weight reduction. Obes Surg. 1996;6(1):44–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Capella JF, Capella RF. Gastro-gastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg. 1999;9(1):22–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Csendes A, Burgos AM, Altuve J, et al. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg. 2009;19(2):135–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Csendes A, Torres J, Burgos AM. Late marginal ulcers after gastric bypass for morbid obesity. Clinical and endoscopic findings and response to treatment. Obes Surg. 2011;21(9):1319–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Garrido Jr AB, Rossi M, Lima Jr SE, et al. Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment: prospective multicentric study. Arq Gastroenterol. 2010;47(2):130–4.CrossRefGoogle Scholar
  26. 26.
    Hartin Jr CW, ReMine DS, Lucktong TA. Preoperative bariatric screening and treatment of Helicobacter pylori. Surg Endosc. 2009;23(11):2531–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Jordan JH, Hocking MP, Rout WR, et al. Marginal ulcer following gastric bypass for morbid obesity. Am Surg. 1991;57(5):286–8.PubMedGoogle Scholar
  28. 28.
    Kalaiselvan R, Exarchos G, Hamza N, Ammori BJ. Incidence of perforated gastrojejunal anastomotic ulcers after laparoscopic gastric bypass for morbid obesity and role of laparoscopy in their management. Surg Obes Relat Dis. 2011;8(4):423–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Lublin M, McCoy M, Waldrep DJ. Perforating marginal ulcers after laparoscopic gastric bypass. Surg Endosc. 2006;20(1):51–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Marano Jr BJ. Endoscopy after Roux-en-Y gastric bypass: a community hospital experience. Obes Surg. 2005;15(3):342–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Patel RA, Brolin RE, Gandhi A. Revisional operations for marginal ulcer after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5(3):317–22.PubMedCrossRefGoogle Scholar
  32. 32.
    Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Ruiz-de-Adana JC, Lopez-Herrero J, Hernandez-Matias A, et al. Laparoscopic hand-sewn gastrojejunal anastomoses. Obes Surg. 2008;18(9):1074–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Sacks BC, Mattar SG, Qureshi FG, et al. Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(1):11–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Sasse KC, Ganser J, Kozar M, et al. Seven cases of gastric perforation in Roux-en-Y gastric bypass patients: what lessons can we learn? Obes Surg. 2008;18(5):530–4.PubMedCrossRefGoogle Scholar
  36. 36.
    Spaulding L. The impact of small bowel resection on the incidence of stomal stenosis and marginal ulcer after gastric bypass. Obes Surg. 1997;7(6):485–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Suggs WJ, Kouli W, Lupovici M, et al. Complications at gastrojejunostomy after laparoscopic Roux-en-Y gastric bypass: comparison between 21- and 25-mm circular staplers. Surg Obes Relat Dis. 2007;3(5):508–14.PubMedCrossRefGoogle Scholar
  38. 38.
    Suter M, Donadini A, Calmes JM, et al. Improved surgical technique for laparoscopic Roux-en-Y gastric bypass reduces complications at the gastrojejunostomy. Obes Surg. 2010;20(7):841–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Vasquez JC, Wayne OD, Farrell TM. Fewer gastrojejunostomy strictures and marginal ulcers with absorbable suture. Surg Endosc. 2009;23(9):2011–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Wheeler AA, de la Torre RA, Fearing NM. Laparoscopic repair of perforated marginal ulcer following Roux-en-Y gastric bypass: a case series. J Laparoendosc Adv Surg Tech A. 2011;21(1):57–60.PubMedCrossRefGoogle Scholar
  41. 41.
    Yang CS, Lee WJ, Wang HH, et al. The influence of Helicobacter pylori infection on the development of gastric ulcer in symptomatic patients after bariatric surgery. Obes Surg. 2006;16(6):735–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Snyder JM. Peptic ulcer following gastric bypass. Obes Surg. 2007;17(10):1419.PubMedCrossRefGoogle Scholar
  43. 43.
    Printen KJ, Scott D, Mason EE. Stomal ulcers after gastric bypass. Arch Surg. 1980;115(4):525–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Frezza EE, Herbert H, Ford R, et al. Endoscopic suture removal at gastrojejunal anastomosis after Roux-en-Y gastric bypass to prevent marginal ulceration. Surg Obes Relat Dis. 2007;3(6):619–22.PubMedCrossRefGoogle Scholar
  45. 45.
    Madan AK, DeArmond G, Ternovits CA, et al. Laparoscopic revision of the gastrojejunostomy for recurrent bleeding ulcers after past open revision gastric bypass. Obes Surg. 2006;16(12):1662–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Siilin H, Wanders A, Gustavsson S, et al. The proximal gastric pouch invariably contains acid-producing parietal cells in Roux-en-Y gastric bypass. Obes Surg. 2005;15(6):771–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Sapala JA, Wood MH, Sapala MA, et al. The micropouch gastric bypass: technical considerations in primary and revisionary operations. Obes Surg. 2001;11(1):3–17.PubMedCrossRefGoogle Scholar
  48. 48.
    Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4(4):353–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Csendes A, Burgos AM, Smok G, et al. Endoscopic and histologic findings of the foregut in 426 patients with morbid obesity. Obes Surg. 2007;17(1):28–34.PubMedCrossRefGoogle Scholar
  50. 50.
    Ramaswamy A, Lin E, Ramshaw BJ, et al. Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery. Arch Surg. 2004;139(10):1094–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Erim T, Cruz-Correa MR, Szomstein S, et al. Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: a preliminary study. World J Surg. 2008;32(9):2021–5.PubMedCrossRefGoogle Scholar
  52. 52.
    D'Hondt MA, Pottel H, Devriendt D, et al. Can a short course of prophylactic low-dose proton pump inhibitor therapy prevent stomal ulceration after laparoscopic Roux-en-Y gastric bypass? Obes Surg. 2010;20(5):595–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Luján JA, Frutos MD, Hernandez Q, et al. Experience with the circular stapler for the gastrojejunostomy in laparoscopic gastric bypass (350 cases). Obes Surg. 2005;15(8):1096–102.PubMedCrossRefGoogle Scholar
  54. 54.
    Ramirez MC, Rodriguez J, Varghese F, et al. Reinforced circular stapler in bariatric surgery. JSLS. 2010;14(3):358–63.PubMedCentralPubMedCrossRefGoogle Scholar
  55. 55.
    Schirmer B, Erenoglu C, Miller A. Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass. Obes Surg. 2002;12(5):634–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Rawlins L, Rawlins MP, Brown CC, Schumacher DL. Effect of Helicobacter pylori on marginal ulcer and stomal stenosis after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2012;9(5):760–4.PubMedCrossRefGoogle Scholar
  57. 57.
    Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002;359(9300):14–22.PubMedCrossRefGoogle Scholar
  58. 58.
    Tytgat GN. Etiopathogenetic principles and peptic ulcer disease classification. Dig Dis. 2011;29(5):454–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol. 1997;24(1):2–17.PubMedCrossRefGoogle Scholar
  60. 60.
    Wilson JA, Romagnuolo J, Byrne TK, et al. Predictors of endoscopic findings after Roux-en-Y gastric bypass. Am J Gastroenterol. 2006;101(10):2194–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996;52 Suppl 5:13–23.PubMedCrossRefGoogle Scholar
  62. 62.
    Hayllar J, Bjarnason I. NSAIDs, Cox-2 inhibitors, and the gut. Lancet. 1995;346(8990):1629.PubMedCrossRefGoogle Scholar
  63. 63.
    Lanas A, Garcia-Rodriguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55(12):1731–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Arroyo MT, Forne M, de Argila CM, et al. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Helicobacter. 2004;9(3):249–54.PubMedCrossRefGoogle Scholar
  65. 65.
    Konturek SJ, Konturek PC, Brzozowski T. Prostaglandins and ulcer healing. J Physiol Pharmacol. 2005;56 Suppl 5:5–31.Google Scholar
  66. 66.
    Kligman MD, Thomas C, Saxe J. Effect of the learning curve on the early outcomes of Laparoscopic Roux en Y gastric bypass. Am Surg. 2003;69(4):304–9.Google Scholar
  67. 67.
    El-Hayek K, Timratana P, Shimizu H, Chand B. Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned? Surg Endosc. 2012;26(10):2789–96.PubMedCrossRefGoogle Scholar
  68. 68.
    Gumbs AA, Duffy AJ, Bell RL. Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis. 2006;2(4):460–3.PubMedCrossRefGoogle Scholar
  69. 69.
    Azagury D, Dumonceau JM, Morel P, et al. Preoperative work-up in asymptomatic patients undergoing Roux-en-Y gastric bypass: is endoscopy mandatory? Obes Surg. 2006;16(10):1304–11.PubMedCrossRefGoogle Scholar
  70. 70.
    Pope GD, Goodney PP, Burchard KW, et al. Peptic ulcer/stricture after gastric bypass: a comparison of technique and acid suppression variables. Obes Surg. 2002;12(1):30–3.PubMedCrossRefGoogle Scholar
  71. 71.
    Racu C, Dutson EP, Mehran A. Laparoscopic gastrojejunostomy revision: a novel approach to intractable marginal ulcer management. Surg Obes Relat Dis. 2010;6(5):557–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Brolin RE, Cody RP. Impact of technological advances on complications of revisional bariatric operations. J Am Coll Surg. 2008;206(3):1137–44.PubMedCrossRefGoogle Scholar
  73. 73.
    Kolkman JJ, Meuwissen SG. A review on treatment of bleeding peptic ulcer: a collaborative task of gastroenterologist and surgeon. Scand J Gastroenterol Suppl. 1996;218:16–25.PubMedCrossRefGoogle Scholar
  74. 74.
    Nguyen NT, Hinojosa MW, Gray J, et al. Reoperation for marginal ulceration. Surg Endosc. 2007;21(11):1919–21.PubMedCrossRefGoogle Scholar
  75. 75.
    St Jean MR, Dunkle-Blatter SE, Petrick AT. Laparoscopic management of perforated marginal ulcer after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(6):668.PubMedCrossRefGoogle Scholar
  76. 76.
    Hedberg J, Hedenstrom H, Nilsson S, et al. Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg. 2005;15(10):1375–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Hedberg J, Hedenstrom H, Sundbom M. Wireless pH-metry at the gastrojejunostomy after Roux-en-Y gastric bypass: a novel use of the BRAVO system. Surg Endosc. 2011;25(7):2302–7.PubMedCrossRefGoogle Scholar
  78. 78.
    Yao X, Forte JG. Cell biology of acid secretion by the parietal cell. Annu Rev Physiol. 2003;65:103–31.PubMedCrossRefGoogle Scholar
  79. 79.
    Sandvik AK, Waldum HL. Aspects of the regulation of gastric histamine release. Scand J Gastroenterol Suppl. 1991;180:108–12.PubMedCrossRefGoogle Scholar
  80. 80.
    Kidd M, Modlin IM, Tang LH. Gastrin and the enterochromaffin-like cell: an acid update. Dig Surg. 1998;15(3):209–17.PubMedCrossRefGoogle Scholar
  81. 81.
    Mason EE, Munns JR, Kealey GP, et al. Effect of gastric bypass on gastric secretion. Am J Surg. 1976;131(2):162–8.PubMedCrossRefGoogle Scholar
  82. 82.
    Giordano S, Salminen P, Biancari F, et al. Linear stapler technique may be safer than circular in gastrojejunal anastomosis for laparoscopic Roux-en-Y gastric bypass: a meta-analysis of comparative studies. Obes Surg. 2011;21(12):1958–64.PubMedCrossRefGoogle Scholar
  83. 83.
    Papasavas PK, Gagne DJ, Donnelly PE, et al. Prevalence of Helicobacter pylori infection and value of preoperative testing and treatment in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4(3):383–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Renshaw AA, Rabaza JR, Gonzalez AM, et al. Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity. Obes Surg. 2001;11(3):281–3.PubMedCrossRefGoogle Scholar
  85. 85.
    Nishikawa K, Sugiyama T, Kato M, et al. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol. 2000;12(6):635–40.PubMedCrossRefGoogle Scholar
  86. 86.
    Jyotheeswaran S, Shah AN, Jin HO, et al. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol. 1998;93(4):574–8.PubMedCrossRefGoogle Scholar
  87. 87.
    Marshall BJ. One hundred years of discovery and rediscovery of Helicobacter pylori and its association with peptic ulcer disease. In: Mobey HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: physiology and genetics. Washington (DC): ASM Press; 2001.Google Scholar
  88. 88.
    Ciociola AA, McSorley DJ, Turner K, et al. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol. 1999;94(7):1834–40.PubMedCrossRefGoogle Scholar
  89. 89.
    Rollason TP. Campylobacter-like organisms in the human stomach. A review. Acta Gastroenterol Belg. 1986;49(1):63–9.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Usha K. Coblijn
    • 1
  • Amin B. Goucham
    • 1
  • Sjoerd M. Lagarde
    • 1
  • Sjoerd D. Kuiken
    • 2
  • Bart A. van Wagensveld
    • 1
  1. 1.Department of SurgerySint Lucas Andreas HospitalAmsterdamThe Netherlands
  2. 2.Department of GastroenterologySint Lucas Andreas HospitalAmsterdamThe Netherlands

Personalised recommendations